Results 181 to 190 of about 23,901 (228)

Denosumab increased bone mineral density but caused marked serum calcium fluctuations in a patient undergoing peritoneal dialysis. [PDF]

CEN Case Rep
Yamada S, Enomoto S, Matsuo K, Sonezaki Y, Torisu K.   +4 more
europepmc   +1 more source

Identifying Incident Medication-Related Osteonecrosis of the Jaw and Antiresorptive Drug Holidays Using Natural Language Processing on Clinical Notes in Men and Women Prescribed Bisphosphonates or Denosumab for Fracture Prevention. [PDF]

Arthritis Care Res (Hoboken)
Budde E, Elam RE, Carbone LD, Le B, Dodson TB, Gerngross PJ, Fink HA, Adler RA, Lo JC, Schousboe JT, Weaver F, Finch D.   +11 more
europepmc   +1 more source

Beyond the T-Score: A Narrative Clinical Review of Adult Endocrine Osteoporosis Care. [PDF]

J Clin Med
Georgescu LM, Igna AD, Popa Tăut EC, Toderaș Herlaș BA, Rațiu IA, Luengo Perez LM, Pașcalău NAM.   +6 more
europepmc   +1 more source

Cardiovascular Outcomes Associated with Romosozumab Versus Denosumab in Chronic Kidney Disease. [PDF]

Medicina (Kaunas)
Chen JY, Chen TY, Tung KK, Deng YL, Lee CY, Li CR, Lee HT.   +6 more
europepmc   +1 more source

Artificial Intelligence for Evidence Synthesis of Emerging Biologics to Improve Skeletal Health in Osteogenesis Imperfecta: Systematic Review and Meta-Analysis. [PDF]

J Med Internet Res
Li C, Dai Z, Tang WC, Gao Z, Chan VKY, Ramirez-Posada M, Kim J, Linos E, Cheung CL, Wong ICK, Dong D, To M, Craig D, Li X.   +13 more
europepmc   +1 more source

Prescription Behaviors of Primary Care Providers in Osteoporosis Management: A Survey. [PDF]

Cureus
Kumar V.
europepmc   +1 more source

Cardiovascular safety of romosozumab versus denosumab for osteoporosis treatment: a multinational real-world data analysis. [PDF]

Ther Adv Musculoskelet Dis
Gusbela BI, Hsu MH, Huang CF, Wu MH, Nugroho DCA, Muhtar MS, Lu CY, Teng MH, Hsu JC.   +8 more
europepmc   +1 more source